Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 (replacing v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-21T20:14:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-07T13:19:08.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, indicating a minor site maintenance or version update; there are no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T16:30:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1, replacing Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-06T11:30:14.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T12:23:44.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    UI and metadata updates were made: a glossary toggle is now displayed, and the 'Last Update Submitted that Met QC Criteria' label capitalization was adjusted. The page now shows a 'No FEAR Act Data' note and the revision is updated to v3.4.0 (from v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-29T06:57:25.000Z thumbnail image

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.